ADAM8 as a novel serological and histochemical marker for lung cancer
about
Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancerInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisADAM8 as a drug target in pancreatic cancer.ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancerDeficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularityThe metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthmaADAM8: a new therapeutic target for asthmaADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer.UHRF1 is a novel diagnostic marker of lung cancer.Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancerADAM8 in squamous cell carcinoma of the head and neck: a retrospective studyN-glycosylation regulates ADAM8 processing and activationKrebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancerA study on biomarkers, cytokines, and growth factors in children with burn injuries.Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.ADAM proteases, ErbB pathways and cancer.Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).Smoking and lung cancer: future research directions.A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.A systematic approach to the development of novel therapeutics for lung cancer using genomic analyses.ADAM8 in asthma. Friend or foe to airway inflammation?The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.Bone metastases in lung cancer. Potential novel approaches to therapy.Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer.Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B.Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer.Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets.Comparative analysis of gingival crevicular fluid a disintegrin and metalloproteinase 8 levels in health and periodontal disease: A clinic-biochemical study.Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.Elevated levels of a disintegrin and metalloproteinase 8 in gingival crevicular fluid of patients with periodontal diseases.Protein predictive signatures for lymph node metastasis of gastric cancer.Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer.Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis.Cell-surface marker discovery for lung cancer.Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.
P2860
Q24294641-67DAC13A-80F5-4B8F-8377-33075C159806Q26767150-736D88FD-90F4-4C44-A0BD-2F90D936D623Q27324447-90DA5C69-FAE7-475C-BC08-7576B27B6C36Q28255938-45D8233D-B666-4D10-A9F1-191DE6C64012Q28512812-E34AEDAC-5502-41DD-983E-813A1D2A1135Q28587244-B3AB8139-2543-4D35-AA78-DF9889A711CDQ28590394-A32CE362-661D-4075-970D-8619B87FE71EQ31148772-3C10F3AD-1D2D-47D3-8BB4-A577A243BBECQ33251551-6C4F9F0D-8F0E-4BD7-84DC-2B5FAA226474Q34005854-62CF5013-E2BE-4750-9D09-27CC4031649DQ34076570-8E0DEF25-73D8-4F12-9064-07419FE2FEBCQ34173701-D9F401DD-4EF7-4958-93B8-75B65683A290Q34580432-24ADD3A7-9668-4031-BC06-EDF618639B78Q34627201-D1946631-EEA2-4B17-83BE-BB83F25C9E5CQ35074445-5D525207-C7C2-482D-9775-F9D66A4BE090Q35279631-9738D1A0-9B66-4B4F-A073-AA2A12EDD164Q35444274-07C69C01-35F4-4C50-83E7-450EF9C2C955Q36187030-F42556B3-CCEA-4FA1-B012-A2A64643AC4EQ36613950-F58FC61F-B55F-408C-A01C-40D01D3CBDB2Q36895457-C48D5676-64C3-499A-9644-DB28551CE40CQ37125335-42C395C9-B6E4-4CC6-AB6B-EFD79E4E6BD8Q37176648-FEC28A3B-B012-4D65-9126-A1483130D91BQ38105238-80C24F13-3060-4E94-A468-858D3884AC27Q38120280-CCFE5855-59E5-42A9-85F4-9BFF35EF7711Q38330908-C2DD8D99-5EE5-4530-BD17-FC4C4013550EQ38406799-ADB15A74-6E9D-4779-A648-A4D9D06924E4Q38541387-E8239191-D2A9-4B70-9DD6-5DEECAA84703Q39210507-DD5D4875-1F72-423F-A257-393365E27F2CQ39275975-87411E7E-6CE7-4E8E-A984-9E2D729C4015Q39706014-F9206062-825D-403F-9631-5F92226A4FA7Q41460801-82B81DE1-61A3-4BFD-B029-85DE571AA1EBQ43219137-2723BE05-B94F-4C2B-8172-465689160060Q43755640-5FD9183F-DA27-448E-885F-6F974AB8E4C4Q43845822-01ABA39E-CA50-4023-B0EC-D30D59834FBEQ46429361-0582E84B-B954-4561-A2A7-C0E314CA64CAQ47426544-D478B1FF-DFAC-4C79-9145-123556A2CAE3Q47844206-38C6B183-CBDA-4AFD-910E-4D4A40B47D8AQ48854161-9CE612EC-ED89-473A-B5D6-FF43B31AE494Q49325404-FC7572B6-486B-4E35-92A8-C879C49A3231Q50488661-DF44FF24-BC49-49FB-A5D3-F841B56420B3
P2860
ADAM8 as a novel serological and histochemical marker for lung cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
ADAM8 as a novel serological and histochemical marker for lung cancer
@ast
ADAM8 as a novel serological and histochemical marker for lung cancer
@en
ADAM8 as a novel serological and histochemical marker for lung cancer
@nl
type
label
ADAM8 as a novel serological and histochemical marker for lung cancer
@ast
ADAM8 as a novel serological and histochemical marker for lung cancer
@en
ADAM8 as a novel serological and histochemical marker for lung cancer
@nl
prefLabel
ADAM8 as a novel serological and histochemical marker for lung cancer
@ast
ADAM8 as a novel serological and histochemical marker for lung cancer
@en
ADAM8 as a novel serological and histochemical marker for lung cancer
@nl
P2093
P3181
P1476
ADAM8 as a novel serological and histochemical marker for lung cancer
@en
P2093
Eiju Tsuchiya
Hitoshi Nishimura
Kouki Inai
Nobuhisa Ishikawa
Nobuoki Kohno
Wataru Yasui
Yataro Daigo
Yusuke Nakamura
P304
P3181
P356
10.1158/1078-0432.CCR-04-1436
P407
P577
2004-12-15T00:00:00Z